These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 38452738)
21. Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon. Tian X; Qiu H; Zhou Z; Wang S; Fan Y; Li X; Chu R; Li H; Zhou R; Wang H J Virol; 2018 Jan; 92(2):. PubMed ID: 29093098 [TBL] [Abstract][Full Text] [Related]
22. Detection and molecular characterization of adenoviruses in Korean children hospitalized with acute gastroenteritis. Lee JI; Lee GC; Chung JY; Han TH; Lee YK; Kim MS; Lee CH Microbiol Immunol; 2012 Aug; 56(8):523-8. PubMed ID: 22530970 [TBL] [Abstract][Full Text] [Related]
23. Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: "Adenovirus Vaccine Within an Adenovirus Vector". Yan Y; Jing S; Feng L; Zhang J; Zeng Z; Li M; Zhao S; Ou J; Lan W; Guan W; Wu X; Wu J; Seto D; Zhang Q Virol Sin; 2021 Jun; 36(3):354-364. PubMed ID: 32458297 [TBL] [Abstract][Full Text] [Related]
25. [The study of prevalence of neutralization antibody against human adenovirus in ophthalmological medical workers]. Ohguchi T; Kaneko H; Tagawa Y; Aoki K; Ohno S; Shiota H Nippon Ganka Gakkai Zasshi; 2007 Dec; 111(12):931-5. PubMed ID: 18186214 [TBL] [Abstract][Full Text] [Related]
26. Seroprevalence of neutralizing antibodies to human adenovirus type 5 in healthy adults in China. Yu B; Zhou Y; Wu H; Wang Z; Zhan Y; Feng X; Geng R; Wu Y; Kong W; Yu X J Med Virol; 2012 Sep; 84(9):1408-14. PubMed ID: 22825819 [TBL] [Abstract][Full Text] [Related]
27. Reassessment of high prevalence human adenovirus detections among residents of two refugee centers in Kenya under surveillance for acute respiratory infections. Wu X; Lu X; Schneider E; Ahmed JA; Njenga MK; Breiman RF; Eidex RB; Erdman DD J Med Virol; 2019 Mar; 91(3):385-391. PubMed ID: 30242854 [TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of human adenovirus type 5 neutralizing antibodies in the Philippines. Francisco AG; Reyes JCB; Tabios IKB; Cruz CJG; Ang MAC; Heralde FM; Lacuna ARG; de Paz-Silava SLM PLoS One; 2023; 18(12):e0293046. PubMed ID: 38039314 [TBL] [Abstract][Full Text] [Related]
29. Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector. Liu M; Tian X; Li X; Zhou Z; Li C; Zhou R PLoS One; 2014; 9(7):e103058. PubMed ID: 25054273 [TBL] [Abstract][Full Text] [Related]
30. Adenoviral Infections in Singapore: Should New Antiviral Therapies and Vaccines Be Adopted? Coleman KK; Wong CC; Jayakumar J; Nguyen TT; Wong AWL; Yadana S; Thoon KC; Chan KP; Low JG; Kalimuddin S; Dehghan S; Kang J; Shamsaddini A; Seto D; Su YCF; Gray GC J Infect Dis; 2020 Feb; 221(4):566-577. PubMed ID: 31563943 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of human infection with respiratory adenovirus in China: A systematic review and meta-analysis. Liu MC; Xu Q; Li TT; Wang T; Jiang BG; Lv CL; Zhang XA; Liu W; Fang LQ PLoS Negl Trop Dis; 2023 Feb; 17(2):e0011151. PubMed ID: 36812245 [TBL] [Abstract][Full Text] [Related]
32. The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines. Pilankatta R; Chawla T; Khanna N; Swaminathan S J Med Virol; 2010 Mar; 82(3):407-14. PubMed ID: 20087930 [TBL] [Abstract][Full Text] [Related]
33. Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines. Li Q; Liu Q; Huang W; Song A; Zhao C; Wu J; Wang Y Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301274 [TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China. Zheng X; Rong X; Feng Y; Sun X; Li L; Wang Q; Wang M; Liu W; Li C; Yang Y; Zhou R; Lu J; Feng L; Chen L Emerg Microbes Infect; 2017 Jun; 6(6):e43. PubMed ID: 28588291 [TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines. Appaiahgari MB; Pandey RM; Vrati S Clin Vaccine Immunol; 2007 Aug; 14(8):1053-5. PubMed ID: 17596429 [TBL] [Abstract][Full Text] [Related]
36. Antibodies to enteric adenoviruses (Ad40 and Ad41) in sera from Iranian children. Saderi H; Roustai MH; Sabahi F J Clin Virol; 2000 Apr; 16(2):145-7. PubMed ID: 10720819 [TBL] [Abstract][Full Text] [Related]
37. Adenoviruses associated with acute gastroenteritis in hospitalized and community children up to 5 years old in Rio de Janeiro and Salvador, Brazil. Filho EP; da Costa Faria NR; Fialho AM; de Assis RS; Almeida MMS; Rocha M; Galvão M; Dos Santos FB; Barreto ML; Leite JPG J Med Microbiol; 2007 Mar; 56(Pt 3):313-319. PubMed ID: 17314359 [TBL] [Abstract][Full Text] [Related]
38. A serological survey of human adenovirus serotype 2 and 5 circulating pediatric populations in Changchun, China, 2011. Yu B; Wang Z; Dong J; Wang C; Gu L; Sun C; Kong W; Yu X Virol J; 2012 Nov; 9():287. PubMed ID: 23176136 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive serotyping and epidemiology of human adenovirus isolated from the respiratory tract of Korean children over 17 consecutive years (1991-2007). Lee J; Choi EH; Lee HJ J Med Virol; 2010 Apr; 82(4):624-31. PubMed ID: 20166176 [TBL] [Abstract][Full Text] [Related]
40. Human Adenovirus Associated with Severe Respiratory Infection, Oregon, USA, 2013-2014. Scott MK; Chommanard C; Lu X; Appelgate D; Grenz L; Schneider E; Gerber SI; Erdman DD; Thomas A Emerg Infect Dis; 2016 Jun; 22(6):1044-51. PubMed ID: 27191834 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]